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Background: The increased prevalence of foot and ankle pathologies in
Rheumatic and Musculoskeletal diseases (RMDs) is well documented1,
however the provision of foot & ankle (F&A) healthcare services for
people with RMDs in Europe has not been evaluated.
Objectives: To assess the current healthcare systems for providing foot
& ankle healthcare services for people with RMDs in Europe.
Methods: A survey was undertaken to evaluate current provision of
F&A health care services for people with RMDs across Europe. A
questionnaire was distributed to all 22 country presidents representing
HP associations within EULAR. The questionnaire used was developed
and piloted (in 7 countries) by the EULAR F&A Study Group, and
structured to capture the provision and type of F&A services for people
with RMDs. When the HP presidents felt unable to answer specific
questions they were encouraged to consult a colleague who may be
better placed to provide the answers.  
Results: Sixteen questionnaires were completed (Norway, Ireland,
Sweden, Hungary, Netherlands, UK, Denmark, Portugal, Italy,
Switzerland, Austria, France, Czech Republic, Spain, Belgium, Malta).
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Of the 16, 13 respondents indicated provision of F&A health care
services in their country, but only three countries had services
specialising in RMD-related F&A problems (Netherlands, UK, Malta).
 The professions providing the care for patients with RMD-related F&A
problems were different depending on the pathology and the country
(Table1). Podiatrists provided care for F&A pain and deformity
problems in 11 countries, but provided F&A ulcer care in only 8
countries.
  Foot problems
F&A pain F&A deformity F&A ulcers
Professions No Countries (N=16) No Countries
(N=16)
No Countries
(N=16)
General Practitioner 14 7 10
Rheumatologist 15 11 10
Rehabilitation Medical Dr 11 10 5
Nurses 9 5 14
Podiatrist 11 11 8
Physiotherapist 14 11 3
Orthotist/prosthetist 14 14 8
Orthopaedic surgeon 12 14 7
 
Table 1: Number of countries reporting which professions are involved
in providing the health services specialising in RMD-related F&A
problems. Only professions that were present in ≥10 countries were
included.
Conclusions: Only 3 countries have F&A health care services
specialised to the needs of people with RMDs. The professions
providing the care varied between countries, and also depended on the
F&A pathology. Interestingly, F&A healthcare services were provided
by professions that do not solely specialised in F&A care.  Further
research is needed to assess the variation of F&A healthcare services
between and within European countries and the impact on healthcare
of various F&A healthcare service designs.
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